Prioritizing Genomic Applications for Action by Level of Evidence: A Horizon-Scanning Method

As evidence accumulates on the use of genomic tests and other health-related applications of genomic technologies, decision makers may increasingly seek support in identifying which applications have sufficiently robust evidence to suggest they might be considered for action. As an interim working p...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Clin Pharmacol Ther
Egile Nagusiak: Dotson, WD, Douglas, MP, Kolor, K, Stewart, AC, Bowen, MS, Gwinn, M, Wulf, A, Anders, HM, Chang, CQ, Clyne, M, Lam, TK, Schully, SD, Marrone, M, Feero, WG, Khoury, MJ
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2014
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4689130/
https://ncbi.nlm.nih.gov/pubmed/24398597
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/clpt.2013.226
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak